ALAN JACKSON KEPT HIS GENETIC ILLNESS PRIVATE FOR A DECADE BEFORE TURNING HIS FINAL TOUR INTO A MILLION-DOLLAR FIGHT FOR A CURE. HE GOT IT FROM HIS FATHER. THERE IS NO TREATMENT. HE SPENT HIS LAST TOUR PAYING FOR ONE ANYWAY. Alan Jackson was diagnosed with Charcot-Marie-Tooth disease in 2011 and said nothing publicly for ten years. When he finally did, on TODAY in 2021, the first thing he explained was where it came from. “It’s genetic. I inherited from my daddy.” Then he laughed at the acronym. CMT — the same three letters as the network that carried his videos for twenty years. It is the most common inherited neuropathy, traced to more than 140 known mutations, affecting about 150,000 Americans and three million people worldwide. It degenerates the peripheral nerves running out to the hands and feet. There are no approved treatments. Not one. He put a dollar from every ticket on the Last Call tour toward the CMT Research Foundation, and a group of the foundation’s donors agreed to match it. By the end it came to more than $2.25 million. The foundation describes what that money funds as drug development aimed at treatments “within our lifetime.” He is sixty-seven and the nerve damage is decades in. He played the last one at Nissan Stadium in Nashville on June 27. A storm pushed him back an hour; he went on after 9:35. Other artists had spent the first two hours singing his catalog. He told the crowd the ride had been long and sweet, and that it started forty years ago that September. The money goes to whoever gets the disease next.
He Got It From His Father Alan Jackson did not make the announcement lightly. For years, he carried the diagnosis privately, keeping the weight of it off the stage and…